메뉴 건너뛰기




Volumn 7, Issue 1, 2014, Pages 51-58

Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients with Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

Author keywords

Heart failure; Kidney; Potassium; Prognosis

Indexed keywords

EPLERENONE; PLACEBO; POTASSIUM;

EID: 84896109810     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.113.000792     Document Type: Article
Times cited : (202)

References (21)
  • 2
    • 84856112414 scopus 로고    scopus 로고
    • Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: Insights from the Eplerenone Post- Acute Myocardial Infarction Heart Failure Efficacy and Survival Study
    • Rossignol P, Cleland JG, Bhandari S, Tala S, Gustafsson F, Fay R, Lamiral Z, Dobre D, Pitt B, Zannad F. Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post- Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. Circulation. 2012;125:271-279.
    • (2012) Circulation , vol.125 , pp. 271-279
    • Rossignol, P.1    Cleland, J.G.2    Bhandari, S.3    Tala, S.4    Gustafsson, F.5    Fay, R.6    Lamiral, Z.7    Dobre, D.8    Pitt, B.9    Zannad, F.10
  • 6
    • 77749292028 scopus 로고    scopus 로고
    • Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors
    • Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol. 2010;5:531-548.
    • Clin J Am Soc Nephrol , vol.2010 , Issue.5 , pp. 531-548
    • Weir, M.R.1    Rolfe, M.2
  • 7
    • 3442888821 scopus 로고    scopus 로고
    • Managing hyperkalemia caused by inhibitors of the renin- angiotensin-aldosterone system
    • Palmer BF. Managing hyperkalemia caused by inhibitors of the renin- angiotensin-aldosterone system. N Engl J Med. 2004;351:585-592.
    • (2004) N Engl J Med , vol.351 , pp. 585-592
    • Palmer, B.F.1
  • 8
    • 63849177462 scopus 로고    scopus 로고
    • American college of cardiology foundation; American Heart Association 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the american college of cardiology foundation
    • Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW; American College of Cardiology Foundation; American Heart Association. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53:e1-e90.
    • (2009) J Am Coll Cardiol , vol.53
    • Hunt, S.A.1    Abraham, W.T.2    Chin, M.H.3    Feldman, A.M.4    Francis, G.S.5    Ganiats, T.G.6    Jessup, M.7    Konstam, M.A.8    Mancini, D.M.9    Michl, K.10    Oates, J.A.11    Rahko, P.S.12    Silver, M.A.13    Stevenson, L.W.14    Yancy, C.W.15
  • 11
    • 77954951329 scopus 로고    scopus 로고
    • Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival
    • Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122:265-272.
    • (2010) Circulation , vol.122 , pp. 265-272
    • Testani, J.M.1    Chen, J.2    McCauley, B.D.3    Kimmel, S.E.4    Shannon, R.P.5
  • 12
    • 84868574835 scopus 로고    scopus 로고
    • RALES Investigators.Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: Insights from RALES (Randomized Aldactone Evaluation Study)
    • Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD; RALES Investigators. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol. 2012;60:2082-2089.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 2082-2089
    • Vardeny, O.1    Wu, D.H.2    Desai, A.3    Rossignol, P.4    Zannad, F.5    Pitt, B.6    Solomon, S.D.7
  • 15
    • 50149119316 scopus 로고    scopus 로고
    • Changes in kidney function following heart failure treatment: Focus on renin-angiotensin system blockade
    • Blankstein R, Bakris GL. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade. Heart Fail Clin. 2008;4:425-438.
    • (2008) Heart Fail Clin , vol.4 , pp. 425-438
    • Blankstein, R.1    Bakris, G.L.2
  • 19
    • 55949112567 scopus 로고    scopus 로고
    • EPHESUS investigators.Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)
    • Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R; EPHESUS Investigators. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2008;118:1643-1650.
    • (2008) Circulation , vol.118 , pp. 1643-1650
    • Pitt, B.1    Bakris, G.2    Ruilope, L.M.3    Dicarlo, L.4    Mukherjee, R.5
  • 20
    • 84886023778 scopus 로고    scopus 로고
    • EMPHASISHF investigators.safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: Analyses of the emphasis-hf study subgroups (Eplerenone in Mild Patients Hospitalization and SurvIval Study in Heart Failure)
    • Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B; EMPHASISHF Investigators. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure). J Am Coll Cardiol. 2013;62:1585-1593.
    • (2013) J Am Coll Cardiol , vol.62 , pp. 1585-1593
    • Eschalier, R.1    McMurray, J.J.2    Swedberg, K.3    Van Veldhuisen, D.J.4    Krum, H.5    Pocock, S.J.6    Shi, H.7    Vincent, J.8    Rossignol, P.9    Zannad, F.10    Pitt, B.11
  • 21
    • 33749631914 scopus 로고    scopus 로고
    • Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction
    • Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation. 2006;114:1572-1580.
    • (2006) Circulation , vol.114 , pp. 1572-1580
    • Smilde, T.D.1    Van Veldhuisen, D.J.2    Navis, G.3    Voors, A.A.4    Hillege, H.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.